MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
October 1, 2008
Shannon Zimmerman
This Trend Is Just Beginning It's a great time to be an investor. No, really. mark for My Articles similar articles
The Motley Fool
October 12, 2010
Selena Maranjian
Don't Underestimate These Great Stocks Companies with rock-bottom P/Es could be true bargains. mark for My Articles similar articles
The Motley Fool
December 21, 2006
Shannon Zimmerman
The Worst Stock for 2007: Research In Motion Good companies don't always make good investments. But is RIM even a good company? Investors, take note. mark for My Articles similar articles
The Motley Fool
November 20, 2009
Dan Caplinger
7 Stocks That Give You Real Value Now that the rally has pushed share prices back up to somewhat pricier levels, you can't afford to get stuck with stocks that turn out to be value traps. Take a look at 7 real-value stocks. mark for My Articles similar articles
The Motley Fool
December 13, 2011
A Brief History of Teva Pharmaceutical's Returns The good news is that, at 15 times earnings, Teva shares now look reasonably valued. mark for My Articles similar articles
The Motley Fool
April 15, 2004
Salim Haji
Deckers' Ugg-ly Valuation As shares of footwear firm Deckers Outdoor continue to soar, concerns about valuation and risk only increase. mark for My Articles similar articles
The Motley Fool
September 8, 2004
Bill Mann
The Self-Confidence of the Naive So many investors believe that they can generate above-average returns by concentrating on things that the market has already priced in. Better to look out longer term, where few others are. mark for My Articles similar articles
The Motley Fool
January 15, 2009
Dan Caplinger
Beware of "Bargain" Stocks Before you go picking cheap stocks willy-nilly, make sure you're not cutting corners on your research -- or you could get a nasty shock in the future. mark for My Articles similar articles
The Motley Fool
August 16, 2010
Dan Caplinger
Don't Ignore These Cheap Stocks Values abound. Don't miss the boat. mark for My Articles similar articles
The Motley Fool
November 10, 2011
A Brief History of Capital One's Returns Capital One's price-to-book value has dropped off a cliff, falling by over 80% over the past 10 years. mark for My Articles similar articles
The Motley Fool
November 17, 2011
A Brief History of Chevron's Returns The reason Chevron was such a boon to shareholders is explained here. mark for My Articles similar articles
The Motley Fool
May 4, 2006
Stephen D. Simpson
A More Realistic Bar for Barr Labs An unpleasant, but not altogether unexpected drop makes this generic drug company and better value for investors. mark for My Articles similar articles
The Motley Fool
November 28, 2011
A Brief History of Amgen's Returns Amgen shares declined 17% over the past decade. What has happened? mark for My Articles similar articles
The Motley Fool
December 12, 2006
Shannon Zimmerman
Steal These Stocks! Despite what you may have heard, you can indeed beat the market while sleeping peacefully at night with world-class mutual funds. mark for My Articles similar articles
The Motley Fool
August 11, 2005
Shannon Zimmerman
The Pros and Cons of Energy Stocks Is now the time to buy or sell? Wise investors intent on tiptoeing through the oil patch may tap superior, long-term returns. mark for My Articles similar articles
The Motley Fool
October 17, 2011
A Brief History of ExxonMobil's Returns How have ExxonMobil's dividends, growth, and valuation multiples each played a role over the past decade? mark for My Articles similar articles
The Motley Fool
July 6, 2009
Dan Caplinger
Are These Stocks Doomed to Drop? A number of stocks don't look anywhere near as cheap as they did a few months ago. Take a look at some examples: J.Crew... Massey Energy... Owens-Illinois... Temple-Inland... mark for My Articles similar articles
The Motley Fool
August 24, 2010
David Meier
Could Amgen Be a Multibagger? Strong returns on equity can generate powerful shareholder returns. mark for My Articles similar articles
The Motley Fool
December 22, 2010
Stephen J. Marini
Are These High-Yield Stocks Too Good to Be True? Look deep into the numbers on high yielders to avoid dividend traps. mark for My Articles similar articles
The Motley Fool
October 22, 2010
Anand Chokkavelu
7 Big Pharma Stocks Near 52-Week Lows Trolling the bottom for upside potential. mark for My Articles similar articles
The Motley Fool
August 12, 2011
Matt Koppenheffer
3 Stocks I Bought During the Panic With Mr. Market lowering prices on nearly everything, I did some shopping. mark for My Articles similar articles
The Motley Fool
August 4, 2009
Matt Koppenheffer
How Long Should You Ride This Rally? This rally in the market has been a great ride, but is it time to hop off? mark for My Articles similar articles
The Motley Fool
November 30, 2011
A Brief History of Coach's Returns Coach shares returned a whopping 1,395% over the last decade. How'd they get there? mark for My Articles similar articles
The Motley Fool
October 13, 2008
Dan Caplinger
What Are Your Stocks Really Worth? Stop flying blind or your portfolio could end up on the side of a mountain. mark for My Articles similar articles
The Motley Fool
October 5, 2011
Dan Caplinger
Has Teva Pharmaceutical Become the Perfect Stock? Teva still looks poised to stay near perfection for the indefinite future. mark for My Articles similar articles
The Motley Fool
April 24, 2009
Joe Magyer
5 Value Traps to Avoid Right Now Don't get suckered into these cash sinkholes. mark for My Articles similar articles
The Motley Fool
December 14, 2009
Rich Smith
This Just In: Upgrades and Downgrades Piper Jaffray plays a wrong note on Teva. mark for My Articles similar articles
The Motley Fool
March 30, 2006
Nathan Parmelee
Time to Change My Tune on Apple? Apple's shares have fallen by 30%, but is that enough to make them an attractive value? mark for My Articles similar articles
The Motley Fool
May 17, 2011
Andrew Tonner
Does ConocoPhillips Deserve a Spot in Your Portfolio? A quick check of their numbers should help get us started. mark for My Articles similar articles
The Motley Fool
June 2, 2005
Matt Thurmond
Quality Systems or Not? Quality Systems' growth prospects were trading at a discount back in 2003. Those days are gone. But does that mean you shouldn't buy? mark for My Articles similar articles
The Motley Fool
July 30, 2009
Selena Maranjian
Making Money With Multiples These stats can help you compare companies to find great investments. mark for My Articles similar articles
The Motley Fool
November 2, 2010
Jeremy Phillips
Time to Sell Amgen? We're seeking danger signs among Fools' most beloved stocks. mark for My Articles similar articles
The Motley Fool
August 1, 2005
Stephen D. Simpson
Teva: Built to Last? Israeli generics giant Teva Pharmaceuticals is a high-quality company trading at a level that should still provide patient investors with solid long-term performance. mark for My Articles similar articles
The Motley Fool
May 18, 2011
Jordan DiPietro
Should You Buy and Hold Teva Pharmaceutical? The Israeli pharma firm passes all four of our retirement portfolio tests. mark for My Articles similar articles
The Motley Fool
April 30, 2010
Dan Caplinger
These Stocks Aren't Worth What You Think When you're trying to figure out what a company is worth, the stock price is the obvious first place to look. But if that's the only thing you look at, you're going to make some huge mistakes in your analysis -- and some investment decisions you'll later regret. mark for My Articles similar articles